m+Medelevator.RU
← Поиск публикаций
International journal of molecular sciences · 2026

Wedelia trilobata (L.) Leaf Extract Induces Autophagy-Mediated Cell Death in HT-29 Colorectal Cancer Cells via Suppression of the Akt/mTOR Signaling Axis.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Duong Tue Minh, Nguyen Thanh Chau Quoc, Waku Tomonori, Kanaori Kenji, Kamei Kaeko

Аннотация

Colorectal cancer remains a global health challenge due to its high mortality and therapy resistance. While Wedelia trilobata (L.) (WT) exhibits pharmacological potential, its specific mechanisms against this cancer are not fully understood. We investigated the anticancer effects of W. trilobata leaf ethanol extract and its n-hexane and chloroform fractions on HT-29 cells. The WT extract significantly inhibited proliferation by inducing G1/S phase arrest and downregulating PCNA mRNA. It triggered substantial DNA damage (increased γ-H2AX) and suppressed the mitogen-activated protein kinase (ERK) pathway. Notably, the WT extract-induced autophagy-mediated cell death, marked by acidic vesicular organelle formation and increased LC3-II levels. Inhibition of autophagy with N-acetylcysteine and 3-methyladenine partially rescued cell viability, restored p-Akt levels, and reduced LC3-II, indicating that cell death is regulated via the ROS-mediated Akt/mTOR signaling axis. Additionally, autophagic flux was validated using chloroquine, which led to a synergistic accumulation of LC3-II. GC-MS analysis identified 48 and 52 compounds in the n-hexane and chloroform fractions, respectively, including metabolites with known antioxidant and antitumoral properties. These findings demonstrate that W. trilobata induces autophagic cell death through ROS-mediated Akt/mTOR inhibition, supporting its potential as a source of innovative colorectal cancer therapeutics.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты